Alkem Laboratories Limited
Alkem Laboratories Limited (ALKEM.NS) Stock Overview
Explore Alkem Laboratories Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
672.6B
P/E Ratio
28.47
EPS (TTM)
$198.43
ROE
0.19%
ALKEM.NS Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Alkem Laboratories Limited (ALKEM.NS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 51.22, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $6332.49.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 28.47 and a market capitalization of 672.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.